Trial Profile
Phase II study of pre-operative chemoradiation using S-1 followed by surgical resection for potentially resectable and locally advanced pancreatic cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Apr 2019
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 27 Jan 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 03 Feb 2010 New trial record